radical prostatectomy, CALGB 90203, Charles Ryan, PSA recurrence, docetaxel use in prostate cancer, CHAARTED trial, STAMPEDE trial, ADT plus docetaxel, radical prostatectomy versus immediate radical prostatectomy.
Zach Klaassen and Rob Svatek explore the potential of cretostimogene, a novel medication for non-muscle invasive bladder cancer. Dr. Svatek describes cretostimogene as an oncolytic…
Louise Emmett discusses the novel copper-64 bisPSMA agent for prostate cancer imaging. She explains its unique features, including a 12-hour half-life and bifid peptide structure,…
Sam Chang engages with Josh Meeks to discuss nadofaragene firadenovec’s role in treating BCG-unresponsive bladder cancer. They consider the significance of clinical trials and FDA…
Ashish Kamat engages with Kamal Pohar and Kelly Bree on bladder cancer surveillance. They discuss the ongoing debate about the utility of various urinary markers…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
TIVO-3 randomized phase 3 trial of tivozanib, vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, CONTACT-03 phase 3 trial, TiNivo-2 trial.
Ruchika Talwar interviews Justin Ziemba about a significant development in kidney stone disease advocacy and research. Dr. Ziemba announces the creation of the Kidney Stone…
Zach Klaassen and Hanan Goldberg discuss the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC), highlighting the impact of PSMA PET scans on diminishing this…
Alicia Morgans hosts a discussion with Paul Eber and Brad Somer to explore the collaborative management of metastatic hormone-sensitive prostate cancer cases. They highlight a…
Alicia Morgans convenes a discussion on managing high-volume metastatic hormone-sensitive prostate cancer, bridging the practices of urology and medical oncology with Jonathan Henderson and Sunil…
